Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYVASO for Pulmonary arterial hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 273 adverse event reports in the FDA FAERS database where TYVASO was used for Pulmonary arterial hypertension.

Most Reported Side Effects for TYVASO

Side Effect Reports % Deaths Hosp.
Death 124 23.7% 123 7
Dyspnoea 69 13.2% 2 55
Pneumonia 44 8.4% 5 42
Cough 37 7.1% 2 13
Headache 32 6.1% 0 17
Fluid retention 26 5.0% 1 23
Chest pain 22 4.2% 0 15
Dizziness 22 4.2% 0 12
Pulmonary arterial hypertension 21 4.0% 7 14
Anaemia 15 2.9% 0 13
Oxygen saturation decreased 15 2.9% 1 11
Condition aggravated 13 2.5% 1 10
Diarrhoea 13 2.5% 1 7
Fall 13 2.5% 0 11
Fatigue 13 2.5% 1 3

Other Indications for TYVASO

Cor pulmonale chronic (143) Product used for unknown indication (56) Pulmonary hypertension (15)

Other Drugs Used for Pulmonary arterial hypertension

TREPROSTINIL (72,609) MACITENTAN (29,246) AMBRISENTAN (27,852) BOSENTAN (12,387) SELEXIPAG (11,861) RIOCIGUAT (9,158) EPOPROSTENOL (8,508) TADALAFIL (7,679) SILDENAFIL (5,239) ILOPROST (2,828)

Related Pages

TYVASO Full Profile All Pulmonary arterial hypertension Drugs TYVASO Demographics TYVASO Timeline